title: Rapidly progressive lupus nephritis associated with golimumab in a patient with systemic lupus erythematosus and rheumatoid arthritis.
authors: Department of Internal Medicine, Kasugai Municipal Hospital, Kasugai, Japan.
authors: Y
authors: Y
authors: Saka
authors: Department of Internal Medicine, Kasugai Municipal Hospital, Kasugai, Japan.
authors: Y
authors: Y
authors: Taniguchi
authors: Department of Internal Medicine, Kasugai Municipal Hospital, Kasugai, Japan.
authors: Y
authors: Y
authors: Nagahara
authors: Department of Internal Medicine, Kasugai Municipal Hospital, Kasugai, Japan.
authors: R
authors: R
authors: Yamashita
authors: Department of Internal Medicine, Kasugai Municipal Hospital, Kasugai, Japan.
authors: M
authors: M
authors: Karasawa
authors: Department of Internal Medicine, Kasugai Municipal Hospital, Kasugai, Japan.
authors: T
authors: T
authors: Naruse
authors: Department of Internal Medicine, Kasugai Municipal Hospital, Kasugai, Japan.
authors: Y
authors: Y
authors: Watanabe
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000097:blood; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D001706:Biopsy; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008181:Lupus Nephritis / Q000139:chemically induced* / Q000628:therapy; D008875:Middle Aged; D006435:Renal Dialysis; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; C529000:golimumab